Clinical Trial Update: Targeted or Chemotherapy Combined With Immunotherapy Versus Chemotherapy for PD-1 Inhibitor Refractory R/M NPC [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating targeted or chemotherapy combined with immunotherapy versus chemotherapy for PD-1 inhibitor-refractory recurrent/metastatic nasopharyng…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Snippet

Sponsor: Sun Yat-sen University | Conditions: Nasopharyngeal Carcinoma | Phase 2 | Status: UNKNOWN